IVP · As filed with the SEC
Inspire Veterinary Partners income statement, by quarter
The statement as Inspire Veterinary Partners presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Unaudited Condensed Consolidated Statements of Operations · USD, except per-share amounts
| USD, except per-share amounts | Q3 2025† 3 months ended Sep 30, 2025 | Q2 2025 3 months ended Jun 30, 2025 | Q1 2025 3 months ended Mar 31, 2025 | Q4 2024† 3 months ended Dec 31, 2024 |
|---|---|---|---|---|
| Total revenue | 4,316,132 | 4,283,534 | 3,639,209 | 3,321,136† |
| Service revenue | 3,138,670 | 3,195,266 | 2,741,029 | 2,452,941† |
| Product revenue | 1,177,462 | 1,088,268 | 898,180 | 868,195† |
| Operating expenses | ||||
| Cost of service revenue | 2,678,940 | 2,435,318 | 2,139,278 | 2,030,310† |
| Cost of product revenue | 850,153 | 871,665 | 785,409 | 756,254† |
| General and administrative expenses | 2,423,707 | 2,650,361 | 2,446,438 | 3,341,153† |
| Debt extinguishment loss | 0† | 689,411 | — | — |
| Depreciation and amortization | 330,498 | 252,316 | 275,392 | 260,329† |
| Gain on sale of business | — | — | — | 0† |
| Total operating expenses | 6,283,298 | 6,899,071 | 5,646,517 | 4,856,848† |
| Loss from operations | (1,967,166) | (2,615,537) | (2,007,308) | (1,535,712)† |
| Other income (expenses): | ||||
| Interest income | 4 | 13 | 8 | 7† |
| Interest expense | (559,111) | (419,044) | (407,736) | (296,799)† |
| Other income (expenses) | — | — | — | 0† |
| Total other expenses | (559,108) | (419,031) | (407,728) | (2,431,010)† |
| Loss before income taxes | (2,526,273) | (3,034,568) | (2,415,036) | (3,966,722)† |
| Net loss | (2,526,273) | (3,034,568) | (2,415,036) | (3,966,722)† |
| Dividend on convertible series A preferred stock | — | — | — | 0† |
| Net loss attributable to class A and B common stockholders | (2,526,273) | (3,034,568) | — | (3,966,722)† |
| Net loss per Class A and B common shares: | ||||
| Class A and B Common Shares | (0.41) | (0.50) | (0.43) | — |
| Class A and B Common Shares | (0.41) | (0.50) | (0.43) | — |
| Weighted average shares outstanding per Class A and B common shares: | ||||
| Class A and B Common Shares | 6,091,057 | 6,031,634 | 5,555,588 | — |
| Class A and B Common Shares | 6,091,057 | 6,031,634 | 5,555,588 | — |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.